Human response to Escherichia coli O157:H7 infection:: Antibodies to secreted virulence factors

被引:116
作者
Li, YL
Frey, E
Mackenzie, AMR
Finlay, BB
机构
[1] Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada
[2] Div Microbiol, Ottawa, ON K1Y 4E9, Canada
关键词
D O I
10.1128/IAI.68.9.5090-5095.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination has been proposed for the prevention of disease due to enterohemorrhagic Escherichia coli (EHEC), but the immune response following human infection, including the choice of potential antigens, has not been well characterized. To study this, sera were obtained from five pediatric patients with acute diarrhea caused by E. coli O157:117 0, 8, and 60 days after hospitalization. These sera were used to examine the immune response to four different EHEC virulence factors: Tir (translocated intimin receptor, which is inserted into the host cell membrane), intimin (bacterial outer membrane protein which binds to Tir), EspA (secreted protein which forms filamentous structures on EHEC surface), and EspB (inserted into the host membrane and cytoplasm). The response to O157:H7 lipopolysaccharide was also examined. Sera were assayed against purified recombinant proteins using immunoblot analysis and by enzyme-linked immunosorbent assay to determine the sera's titers to each of the antigens in all patients, We found that there was little reaction to EspA EspB, and intimin in the acute-phase sera, although there was some reactivity to Tir. By day 8, titers of antibody to all four virulence factors were present in all patients, with a very strong response against Tir (up to a titer of 1:256,000), especially in hemolytic-uremic syndrome patients, and lesser strong responses to the other three antigens. The titer to the antigens 60 days after hospitalization was decreased but was still highest for Tir. These results suggest that there is a strong immune response to Tir, and to a lesser extent to the other three virulence factors, following EHEC disease, indicating that these bacterial molecules are potential vaccine candidates for preventing EHEC disease. They also suggest that bacterial virulence factors that are inserted into host cells during infection by type III secretion systems (Tir or EspB) are still recognized by the host immune response.
引用
收藏
页码:5090 / 5095
页数:6
相关论文
共 26 条
[11]   THE EPIDEMIOLOGY OF INFECTIONS CAUSED BY ESCHERICHIA-COLI O157-H7, OTHER ENTEROHEMORRHAGIC ESCHERICHIA-COLI, AND THE ASSOCIATED HEMOLYTIC UREMIC SYNDROME [J].
GRIFFIN, PM ;
TAUXE, RV .
EPIDEMIOLOGIC REVIEWS, 1991, 13 :60-98
[12]  
Griffin PM, 1998, ESCHERICHIA COLI O15, P15
[13]   Type III protein secretion systems in bacterial pathogens of animals and plants [J].
Hueck, CJ .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1998, 62 (02) :379-+
[14]   Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system [J].
Jarvis, KG ;
Kaper, JB .
INFECTION AND IMMUNITY, 1996, 64 (11) :4826-4829
[15]   Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus [J].
Jenkins, C ;
Chart, H ;
Smith, HR ;
Hartland, EL ;
Batchelor, M ;
Delahay, RM ;
Dougan, G ;
Frankel, G .
JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (01) :97-101
[16]   The nature of immunity to the Escherichia coli Shiga toxins (verocytotoxins) and options for toxoid immunization [J].
Karmali, MA .
JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1998, 51 :S26-S35
[17]   Enteropathogenic E-coli (EPEC) transfers its receptor for intimate adherence into mammalian cells [J].
Kenny, B ;
DeVinney, R ;
Stein, M ;
Reinscheid, DJ ;
Frey, EA ;
Finlay, BB .
CELL, 1997, 91 (04) :511-520
[18]   A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells [J].
Knutton, S ;
Rosenshine, I ;
Pallen, MJ ;
Nisan, I ;
Neves, BC ;
Bain, C ;
Wolff, C ;
Dougan, G ;
Frankel, G .
EMBO JOURNAL, 1998, 17 (08) :2166-2176
[19]   HEMOLYTIC-UREMIC SYNDROME - AN ANALYSIS OF THE NATURAL-HISTORY AND PROGNOSTIC FEATURES [J].
LOIRAT, C ;
SONSINO, E ;
MORENO, AV ;
PILLION, G ;
MERCIER, JC ;
BEAUFILS, F ;
MATHIEU, H .
ACTA PAEDIATRICA SCANDINAVICA, 1984, 73 (04) :505-514
[20]   DETECTION OF SERUM ANTIBODIES TO THE LIPOPOLYSACCHARIDE OF ESCHERICHIA-COLI-O103 IN PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME [J].
LUZZI, I ;
TOZZI, AE ;
RIZZONI, G ;
NICCOLINI, A ;
BENEDETTI, I ;
MINELLI, F ;
CAPRIOLI, A .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :514-515